Pembrolizumab shows promising activity against head and neck cancer

Nivolumab shows highly promising activity in advanced liver cancer in early-stage trial

Genomic marker predicts anti-PD-1 response in several cancers

ecancermedicalscience editor's choice for May 2015

Prostate cancer and pharmacokinetics: Expert discussion

Using the FALCON contouring platform to improve radiation oncologists' technique

Developing technical improvements to bladder radiotherapy using online imaging

Measuring the true financial costs of radiotherapy

Calypso-based MLC tracking with TrueBeam simulation

Advances in prostate cancer focal radiation treatments

Targeted Intraoperative radiotherapy plus lumpectomy non-inferior to EBRT in preventing breast cancer recurrence

Comparison of coplanar and non-coplanar beam plans as treatment for prostate SBRT